New pill for MS enters early human testing
Disease control
Recruiting now
This early-phase trial is testing an oral drug called VT7208 in healthy volunteers and people with multiple sclerosis (MS). The study has three parts: first, checking safety and how the drug moves through the body in healthy adults; second, seeing how food affects the drug; and t…
Phase: PHASE1, PHASE2 • Sponsor: Vidya Therapeutics Inc • Aim: Disease control
Last updated Jun 26, 2026 13:08 UTC